Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation

Completed · Phase 3

Conditions studied: Atrial Fibrillation, Hypertension

In brief

The objective of this trial is to determine the role of renal sympathetic denervation in the prevention of atrial fibrillation (AF) recurrence in patients with hypertension for whom a catheter-based AF ablation procedure is planned. Patients will be randomized to either AF catheter ablation (usual therapy) or AF catheter ablation plus renal sympathetic denervation.

Key facts

Study ID
NCT01873352
Run by
Meshalkin Research Institute of Pathology of Circulation
People needed
302
Starts
2013-06-20
Expected to finish
2019-03-01
Last updated by the study team
2019-09-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.